<DOC>
	<DOCNO>NCT00337532</DOCNO>
	<brief_summary>The purpose clinical research study learn paclitaxel-cisplatin combination regimen give neoadjuvant set active locally advanced head neck cancer . safety treatment also study .</brief_summary>
	<brief_title>A Phase II Trial Neoadjuvant Paclitaxel Cisplatin Patients With Locally Advanced Head Neck Cancer</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Locally advanced , Stage IIIV ( except M1 ) , hand neck cancer &gt; = 1 measurable lesion previously treat head neck cancer history another malignancy organ allograft preexiting neuropathy &gt; = CTC grade 2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>